As a result of prolonged use and overuse of nasal decongestants, the Belgian Health Authorities have decided to switch intranasal corticosteroids to OTC-status. OTC-use is recommended especially for intranasal corticosteroids with low systemic absorption e.g. mometasone and fluticasone. These days, a good opportunity for the public pharmacists to stress their advising role and point out to patients that, unlike the nasal vasoconstrictors, there will be no immediate relieve when using intranasal corticosteroids.
Recent Posts
- Obligation for Manufacturers to Notify Interruptions or Discontinuations in the Supply of Medical Devices and IV Diagnostic Medical Devices
- New Royal Decree manufacturing and marketing of food supplements
- Use of German in food supplements
- FAMHP – Validity GDP-certificate (expiring end Dec 2024 or in 2025)
- KOAG KAG: new rates and procedure as from 2025